The results of qPCR and immunohistochemistry showed that the expression of TRIM22 mRNA and protein was abnormally decreased in gastric cancer, as well as in gastric cancer cells, which indicated that there was an abnormal transcription of the TRIM22 gene in gastric cancer. This evidence concerns the gene TRIM22 and gastric cancer.